Adjuvant treatment after orthotopic liver transplantation: Is it really necessary?

ONCOLOGY

Volumn 23, Issue 14, 2009, Pages

  Kim, Richard ^a   Tan, Ann ^a   Estfan, Bassam ^a   Aucejo, Federico ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IODINATED POPPYSEED OIL; LICARTIN; MITOMYCIN; MITOXANTRONE; MONOCLONAL ANTIBODY; PLACEBO; RAPAMYCIN; SORAFENIB; TACROLIMUS; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL TRIAL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW;

EID: 74249115137     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005.
2. El-Serag HB, Davila JA, Petersen NJ, et al: The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med 139:817-823, 2003.
3. Furuta T, Sonoda T, Matsumata T, et al: Hepatic resection for a hepatocellular carcinoma larger than 10 cm. J Surg Oncol 51:114-117, 1992.
4. Nagasue N, Kohno H, Chang YC, et al: Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375-384, 1993.
5. Samuel M, Chow PK, Chan Shih-Yen E, et al: Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev 1:CD001199, 2009.
6. Penn I: Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726-734, 1991.
7. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699, 1996.
8. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394-1403, 2001.
9. Silva M, Moya A, Berenguer M, et al: Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 14:1449-1460, 2008.
10. Liang TB, Li DL, Liang L, et al: Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: Efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 85:863-869, 2008.
11. Molmenti EP, Klintmalm GB: Liver transplantation in association with hepatocellular carcinoma: An update of the International Tumor Registry. Liver Transpl 8:736-748, 2002.
12. Kirimlioglu H, Dvorchick I, Ruppert K, et al: Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications. Hepatology 34:502-510, 2001.
13. Aucejo F, Kim R, Zein N, et al: Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl 15:169-176, 2009.
14. Deli G, Jin CH, Mu R, et al: Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 11:960-963, 2005.
15. Dvorchik I, Schwartz M, Fiel MI, et al: Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl 14:443-450, 2008.
16. Stone MJ, Klintmalm GB, Polter D, et al: Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients. Gastroenterology 104:196-202, 1993.
17. Cherqui D: Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 5:35-40, 1998.
18. Soderdahl G, Backman L, Isoniemi H, et al: A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int 19:288-294, 2006.
19. Pokorny H, Gnant M, Rasoul-Rockenschaub S, et al: Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? Am J Transplant 5:788-794, 2005.
20. Olthoff KM, Rosove MH, Shackleton CR, et al: Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 221:734-741, 1995.
21. Bernal E, Montero JL, Delgado M, et al: Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation. Transplant Proc 38:2495-2498, 2006.
22. Graziadei I, Kelly T, Schirmer M, et al: Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2,2-difluorodeoxycytidine on human hepatoma HepG2 cells. J Hepatol 28:504-509, 1998.
23. Hsieh CB, Chou SJ, Shih ML, et al: Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 34:906-910, 2008.
24. Carr BI, Selby R, Madariaga J, et al: Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplant Proc 25:1128-1129, 1993.
25. Cherqui D, Piedbois P, Pierga JY, et al: Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer 73:2721-2726, 1994.
26. Bismuth H, Morino M, Sherlock D, et al: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387-394, 1992.
27. Roayaie S, Frischer JS, Emre SH, et al: Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533-539, 2002.
28. Mazzaferro V, Llovet JM, Miceli R, et al: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 10:35-43, 2009.
29. Marelli L, Shusang V, Senzolo M, et al: Repeated courses of transarterial embolization with polyvinyl alcohol particles: long life elixir in a cirrhotic patient with unresectable hepatocellular carcinoma. Eur J Gastroenterol Hepatol 19:329-332, 2007.
30. Xiong ZP, Yang SR, Xiao EH, et al: [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma]. Zhonghua Zhong Liu Za Zhi 25:562-565, 2003.
31. Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390, 2008.
32. Xu J, Shen ZY, Chen XG, et al: A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 45:269-276, 2007.
33. Zhou J, Wang Z, Wu ZQ, et al: Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria. Transplant Proc 40:3548-3553, 2008.
34. Zimmerman MA, Trotter JF, Wachs M, et al: Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl 14:633-638, 2008.
35. Roayaie S, Schwartz JD, Sung MW, et al: Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Liver Transpl 10:534-540, 2004.
36. Bassanello M, Vitale A, Ciarleglio FA, et al: Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: Impact on survival or HCV recurrence timing. Transplant Proc 35:2991-2994, 2003.
37. Chan EY, Larson AM, Fix OK, et al: Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies. Liver Transpl 14:956-965, 2008.
38. Vona G, Estepa L, Beroud C, et al: Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 39:792-797, 2004.